These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38158206)

  • 1. [Pregnancy and breastfeeding in Crohn's disease].
    Sonnenberg E; Siegmund B
    Dtsch Med Wochenschr; 2024 Jan; 149(1-02):46-56. PubMed ID: 38158206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis.
    Nielsen OH; Gubatan JM; Juhl CB; Streett SE; Maxwell C
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):74-87.e3. PubMed ID: 32931960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates in the management of inflammatory bowel disease during pregnancy.
    Bell SJ; Flanagan EK
    Med J Aust; 2019 Apr; 210(6):276-280. PubMed ID: 30905081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of inflammatory bowel disease in pregnancy.
    Vermeire S; Carbonnel F; Coulie PG; Geenen V; Hazes JM; Masson PL; De Keyser F; Louis E
    J Crohns Colitis; 2012 Sep; 6(8):811-23. PubMed ID: 22595185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
    Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life.
    Kanis SL; Modderman S; Escher JC; Erler N; Beukers R; de Boer N; Bodelier A; Depla ACTM; Dijkstra G; van Dijk ARM; Gilissen L; Hoentjen F; Jansen JM; Kuyvenhoven J; Mahmmod N; Mallant-Hent RC; van der Meulen-de Jong AE; Noruzi A; Oldenburg B; Oostenbrug LE; Ter Borg PCJ; Pierik M; Romberg-Camps M; Thijs W; West R; de Lima A; van der Woude CJ;
    Gut; 2021 Jul; 70(7):1266-1274. PubMed ID: 33046558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.
    Julsgaard M; Hvas CL; Gearry RB; Gibson PR; Fallingborg J; Sparrow MP; Bibby BM; Connell WR; Brown SJ; Kamm MA; Lawrance IC; Vestergaard T; Svenningsen L; Baekdal M; Kammerlander H; Walsh A; Boysen T; Bampton P; Radford-Smith G; Kjeldsen J; Andrews JM; Subramaniam K; Moore GT; Jensen NM; Connor SJ; Wildt S; Wilson B; Ellard K; Christensen LA; Bell SJ
    Inflamm Bowel Dis; 2020 Jan; 26(1):93-102. PubMed ID: 31141607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation.
    Nielsen OH; Gubatan JM; Kolho KL; Streett SE; Maxwell C
    Lancet; 2024 Mar; 403(10433):1291-1303. PubMed ID: 38458222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of anti-TNF agents in pregnancy.
    De Felice KM; Kane S
    J Allergy Clin Immunol; 2021 Sep; 148(3):661-667. PubMed ID: 34489011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation.
    Schulze H; Esters P; Dignass A
    Aliment Pharmacol Ther; 2014 Nov; 40(9):991-1008. PubMed ID: 25200000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.
    Bröms G; Granath F; Stephansson O; Kieler H
    Scand J Gastroenterol; 2016 Dec; 51(12):1462-1469. PubMed ID: 27739352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
    Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Leung KK; Tandon P; Govardhanam V; Maxwell C; Huang V
    Inflamm Bowel Dis; 2021 Mar; 27(4):550-562. PubMed ID: 32469057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs for the treatment of IBD during conception, pregnancy, and lactation.
    Pugliese D; Privitera G; Gisbert JP; Chaparro M
    Dig Liver Dis; 2024 Feb; 56(2):235-241. PubMed ID: 37718225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
    Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M
    Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.
    Boyd HA; Basit S; Harpsøe MC; Wohlfahrt J; Jess T
    PLoS One; 2015; 10(6):e0129567. PubMed ID: 26083614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
    Wang Y; Wang J; Pekow J; Dalal S; Cohen RD; Ollech J; Israel A; Shogan BD; Micic D; Cannon L; Umanskiy K; Hurst R; Hyman N; Rubin DT; Sakuraba A
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2090-2095. PubMed ID: 31169926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.